₹ 29.00
-0.60 (-2.03%)
BSE
G
Goldline Pharmaceutical
₹ 29.00
BSE
Goldline Pharmaceutical EPS Summary
The latest quarterly EPS of Goldline Pharmaceutical as of Q4 Mar 2026 stands at ₹2.18. This is a 118.00% growth quarter on quarter. For the FY2026 the EPS of Goldline Pharmaceutical stands at ₹5.97. This is a 45.26% growth compared with FY2025.
Goldline Pharmaceutical EPS
EPS by Peers
Sorry, No Data Available at this Moment!

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

